|
While PUVA may 'cure' some mycosis fungoides, a carcinogen risk remains.(Dermatologic Therapy)
Publication: Skin & Allergy News Publication Date: 01-JUN-07 Author: Jancin, Bruce
|
|
COPYRIGHT 2007 International Medical News Group
MAUI, HAWAII -- Long-term efficacy of PUVA in a subset of mycosis fungoides patients is such that "I think we can start using the term cure," Dr. Joan Guitart said at the annual Hawaii Dermatology Seminar sponsored by Skin Disease Education Foundation.
Cure has been elusive in cutaneous T-cell lymphoma. Oncologists have been unable to show improvement in prognosis, even with early aggressive chemotherapy "That word, cure, is almost taboo in oncology,'" observed Dr. Guitart, professor of dermatology at Northwestern University, Chicago.
Northwestern was one...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
